Individualized flu immune responses revealed by high-throughput sequencing

Researchers have shown that it is possible to create personalized, individual-specific measurements of the antibody repertoire in response to influenza vaccination using high-throughput DNA sequencing technology.

Furthermore, they have provided molecular characterization of defects in the humoral immune response as a result of aging.

Stephen Quake (Stanford University School of Medicine, California, USA) and colleagues analyzed over 5 million antibody heavy chains and compared isotype diversity, lineage structure, and mutational activity in different age groups before and 1 week and 1 month after influenza vaccination.

As reported in Science Translational Medicine, the team amplified influenza-specific antibody sequences from single-sorted plasmablasts for two separate individuals. This showed that in one person, heavy-chain plasmablast sequences overlapped with antibody lineages with smaller numbers of sequencing reads compared with those from the other individual, in whom many plasmablast sequences were in the top lineage containing the majority of the sequencing reads.

"This may reflect structural differences in repertoire between these two subjects because one has a dominant lineage and the other one has a more even distribution," say the researchers, who add that "the detailed topology of each lineage may contain information about how antigen selection and antibody affinity maturation work in concert in shaping the antibody repertoire."

Further analysis showed that between 1 week and 1 month after vaccination, there was a decrease in the abundance of the immunoglobulin (Ig)M isotype on naïve B (NB) cells in 16 of 17 participants. This decrease coincided with an increase in isotypes IgA and IgG, suggesting "that a portion of the NB cells may have undergone switching and the antibody transcript copy numbers of these isotypes may also have increased as a result of the vaccine stimulation."

Interestingly, the extent of the reduction in IgM decreased with age, with mean reductions of 11.1% in those aged 8 to 17 years, 6.5% in those aged 18 to 30 years, and 6.0% in those aged 70 to 100 years. In addition, analyses of flow cytometry sequence data showed that the number of lineages with isotype switches decreased with age.

The researchers also report that elderly individuals (aged 70 to 100 years) had significantly fewer lineages than other age groups both before and after vaccination. This indicates an "altered repertoire structure and potentially a smaller pool of diversity for the immune repertoire to draw upon in vaccine response."

Finally, the elderly had the highest number of amino acid mutations in the IgG fraction both at 1 week and 1 month after vaccination, while they remained low and similar to the IgM fraction in other age groups at both time points.

"This approach to immune system characterization may be generally applicable to the development of new vaccines and may also help identify which individuals respond to a given vaccine," say Quake et al.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2018, August 23). Individualized flu immune responses revealed by high-throughput sequencing. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20130211/Individualized-flu-immune-responses-revealed-by-high-throughput-sequencing.aspx.

  • MLA

    Robertson, Sally. "Individualized flu immune responses revealed by high-throughput sequencing". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20130211/Individualized-flu-immune-responses-revealed-by-high-throughput-sequencing.aspx>.

  • Chicago

    Robertson, Sally. "Individualized flu immune responses revealed by high-throughput sequencing". News-Medical. https://www.news-medical.net/news/20130211/Individualized-flu-immune-responses-revealed-by-high-throughput-sequencing.aspx. (accessed November 23, 2024).

  • Harvard

    Robertson, Sally. 2018. Individualized flu immune responses revealed by high-throughput sequencing. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20130211/Individualized-flu-immune-responses-revealed-by-high-throughput-sequencing.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
H5N1 bird flu is mutating fast and jumping to mammals - could the next pandemic be here?